GENENTECH, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1976-01-01
- Employees
- 11.1K
- Market Cap
- -
- Website
- http://www.gene.com
A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT01814709
A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)
Completed
- Conditions
- Multiple Myeloma, Neoplasms
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 662
- Registration Number
- NCT01804140
A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 92
- Registration Number
- NCT01772290
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
Phase 2
Completed
- Conditions
- Cytomegalovirus Infections
- Interventions
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT01753167
- Locations
- 🇫🇷
Hopital Pellegrin-CHU de Bordeaux; Service de Neurologie, Bordeaux, France
🇫🇷Hopital Necker, Paris, France
🇫🇷Hopital Rangueil; Gastro Enterologie Et Nutrition, Toulouse, France
The Management of Schizophrenia in Clinical Practice (MOSAIC)
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 557
- Registration Number
- NCT01746134
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2017-04-24
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT01740336
- Locations
- 🇺🇸
Pacific Cancer Medical Center, Anaheim, California, United States
🇺🇸Helen & Harry Gray Cancer Center-Hartford Hospital-CCD PRIME; Research, Hartford, Connecticut, United States
🇺🇸Oncology Specialists, S.C., Park Ridge, Illinois, United States
The Mycophenolate Pregnancy Registry
Recruiting
- Conditions
- Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
- First Posted Date
- 2012-11-26
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT01733082
- Locations
- 🇺🇸
Quintiles Outcome, Cambridge, Massachusetts, United States
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2020-02-20
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT01723826
- Locations
- 🇨🇦
Toronto Memory Program (Neurology Research Inc.), Toronto, Ontario, Canada
🇺🇸University of California Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Margolin Brain Institute, Fresno, California, United States
A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis
Phase 4
Completed
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: dornase alfa [Pulmozyme®]
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT01712334
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT01711762
© Copyright 2025. All Rights Reserved by MedPath